INNOGENE Co.,Ltd. (KOSDAQ:344860)
South Korea
· Delayed Price · Currency is KRW 1,432.00
-25.00 (-1.72%)
At close: Mar 6, 2026
INNOGENE Revenue
INNOGENE had revenue of 2.14B KRW in the quarter ending September 30, 2025, with 11.70% growth. This brings the company's revenue in the last twelve months to 7.85B, down -23.88% year-over-year. In the year 2024, INNOGENE had annual revenue of 8.94B, down -11.45%.
Revenue (ttm)
7.85B
Revenue Growth
-23.88%
P/S Ratio
2.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.96B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Csa Cosmic | 31.61B |
| Bonne | 50.94B |
| Medience | 48.55B |
| Nord Mason | 21.26B |
| Outin Futures | 41.62B |
| Ha U Dong Chun | 1.89B |
| KMPHARMACEUTICAL | 15.09B |
| Beauty Skin | 60.81B |